Abouzid, Khaled

khaled.abouzid@pharma.asu.edu.eg

Department of Pharmaceutical Chemistry - Pharmacy
Interests: Anticancer drug discovery, design and synthesis, Antimicrobial,
Internal ID: rp12178
  • 2,885 Scopus Citations
  • 592 PubMed Citations

khaled__.jpg picture
 
 
Loading... 2 0 20 0 false
 
Full Name
Abouzid, Khaled
 
 
Personal Site
 
Scopus Author ID
 
WOS ID
 
Biography
Dr. Khaled Abouzid is a Professor of Pharmaceutical Chemistry, Faculty of Pharmacy, Ain Shams University, Prominent Scholar in Drug Discovery, Co-founding Director of Center of Drug Discovery and Development Research ASU He was nominated as the Acting Dean of the Faculty of Pharmacy, University of Sadat City from 8-2018 to 8-2022. He is currently a member of national pharmaceutical chemistry promotion committee
Dr. Abouzid’s research is directed towards drug discovery of bioactive small molecules with special emphasis on cannabinoids, targeted anticancer, anti-inflammatory, anti-viral anti-microbial agents and enzyme inhibitors. He has published over 150 research papers, two books and filed 14 patents in medicinal chemistry. He has Scopus H index of 28. He has supervised over 100 Master and PhD students in 7 universities. Dr Abouzid has research collaborations with German, British, Swedish, Canadian and US universities. He has also organized and presided over 34 international symposia and conferences.
Dr. Abouzid obtained his B.Sc. degree in Pharmaceutical Sciences from Cairo University in 1985, and his PhD. joint degree in Organic Chemistry from the Faculty of Pharmacy, Cairo University and School of Pharmacy University of Connecticut, USA.
Dr. Abouzid started his career in 1995 as a lecturer of Organic Chemistry at Cairo University, Faculty of Pharmacy. In 2001, he moved to the Department of Pharmaceutical Chemistry, Ain Shams University, and was promoted to Associate Professor in 2003. He did postdoctoral work with Professor Jochen Lehman of the Friedrich-Schiller-Universität Jena, Germany.

Publications

Refined By:
Author:  Abou El Ella, Dalal
Date Issued:  [2010 TO 2019]

Results 1-15 of 15 (Search time: 0.0 seconds).

Issue DateTitleAuthor(s)
125-Mar-2019Design and Synthesis of New Quinoxaline Derivatives as Anticancer Agents and Apoptotic InducersEl Newahie, Aliya M S; Nissan, Yassin M; Ismail, Nasser S M; Abou El Ella, Dalal ; Khojah, Sohair M; Abouzid, Khaled 
22019Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activityElsayed, Nevine M Y; Serya, Rabah ; Tolba, Mai ; Ahmed, Marawan; Barakat, Khaled; Abou El Ella, Dalal ; Khaled A M Abouzid 
315-Jul-2018Synthesis and biological evaluation of novel 2-oxo-1,2-dihydroquinoline-4-carboxamide derivatives for the treatment of esophageal squamous cell carcinomaShahin, Mai I; Roy, Joyeeta; Hanafi, Maha; Wang, Dongyao; Luesakul, Urarika; Chai, Yifeng; Muangsin, Nongnuj; Lasheen, Deena S. ; Neamati, Nouri; Khaled A M Abouzid ; Abou El Ella, Dalal 
4May-2016Quinoxaline-Based Scaffolds Targeting Tyrosine Kinases and Their Potential Anticancer ActivityEl Newahie, Aliya M S; Ismail, Nasser S M; Abou El Ella, Dalal ; Abouzid, Khaled 
52016Design, synthesis and biological evaluation of indazole–pyrimidine based derivatives as anticancer agents with anti-angiogenic and antiproliferative activitiesElsayed, Nevine M. Y.; Abou El Ella, Dalal ; Serya, Rabah A. T.; Tolba, Mai F.; Shalaby, Raed; Khaled A M Abouzid 
62015Thieno[2,3-d]pyrimidine based derivatives as kinase inhibitors and anticancer agentsElrazaz, Eman ; Abou El Ella, Dalal ; Khaled A M Abouzid ; Rabah A.T. Serya; Nasser S.M. Ismail
72015Molecular modeling design, synthesis, and anti-hyprglycemic evaluation of certain 5-(aryl-alkoxy-benzylidine)-imidazolidine-2,4-dione derivatives as potential PPAR gamma agonistsIsmail, MAH; Abouzid, Khaled ; Abdou, NS; Lahham, A; Abou El Ella, Dalal 
8Oct-2014Design, synthesis and biological evaluation of type-II VEGFR-2 inhibitors based on quinoxaline scaffoldShahin, Mai I; Abou El Ella, Dalal ; Ismail, Nasser S M; Abouzid, Khaled 
9Jun-2014Molecular design and synthesis of 1,4-disubstituted piperazines as α(1)-adrenergic receptor blockersHussein, Mohammed M; Serya, Rabah ; Abdel Naby, Rana M; Al-Abd, Ahmed M; Saleh, Dalia O; El-Eraky, Wafaa I; Khaled A M Abouzid ; Abou El Ella, Dalal 
10Oct-2013Molecular design and synthesis of HCV inhibitors based on thiazolone scaffoldAl-Ansary, Ghada H; Ismail, Mohamed A H; Abou El Ella, Dalal ; Eid, Sameh; Abouzid, Khaled 
1115-May-2013Analogs design, synthesis and biological evaluation of peptidomimetics with potential anti-HCV activityLasheen, Deena S. ; Ismail, Mohamed A H; Ismail, Nasser S M; Eid, Sameh; Vleck, Susan; Glenn, Jeffrey S; Watts, Andrew G; Abouzid, Khaled ; Abou El Ella, Dalal 
12Nov-2012A highly selective structure-based virtual screening model of Palm I allosteric inhibitors of HCV Ns5b polymerase enzyme and its application in the discovery and optimization of new analoguesMahmoud, Amr H; Ismail, Mohamed A H; Abouzid, Khaled ; Abou El Ella, Dalal 
131-Apr-2012Integrated structure-based activity prediction model of benzothiadiazines on various genotypes of HCV NS5b polymerase (1a, 1b and 4) and its application in the discovery of new derivativesIsmail, Mohamed A H; Abou El Ella, Dalal ; Khaled A M Abouzid ; Mahmoud, Amr H
14Feb-2011Molecular modeling study and synthesis of quinazolinone-arylpiperazine derivatives as α1-adrenoreceptor antagonistsAbou-Seri, Sahar Mahmoud; Abouzid, Khaled ; Abou El Ella, Dalal 
152010Computer - based drug design, synthesis and biological evaluation of new pyrimidinone derivatives linked to arylpiperazine and 2 '-carbethoxy-biphenylylmethyl moeities as alpha(1)-adrenoceptor antagonists and angiotensin II AT(1) receptor antagonistsIsmail, MAH; Abouzid, Khaled ; Al-Ansary, GHA; Abou El Ella, Dalal